@PlantMam
They all end at different times, with the final one exiting the study in 2019 (so spent approx 5 years on blockers?)
Seeing as it’s taken a lot of drama to get this bit published, the likelihood of follow up data seems pretty small.
I noticed a year or so ago that one of the parent-of-trans-kids activists was trying to find some of the study participants but I don’t think he was successful.
I will look through some of the board meeting minutes later to see if I can find anything relevant. Looks like loads of ‘audits’ of patient info have been promised. Wonder how many of them have been completed?
The participants were recruited over 3 years, and stayed on puberty blockers for between 1-4 years before going onto cross-sex hormones at 16 years (except for the one who didn't).
The cohort consisted of 44 sequentially eligible young people, aged 12 to 15 years, who were recruited between April 2011 and April 2014 and who commenced GnRHa treatment between June 2011 and April 2015
Participants were followed up in the endocrine clinic, 3-6 monthly in the first 18 months and 12-monthly thereafter, till the end of the treatment pathway, defined as the date on or after the 16th birthday when a decision was made to either cease GnRHa or start cross-sex hormones. The final participant completed the pathway in February 2019.
Sample sizes necessarily varied across follow-up as young people were recruited at different ages but left the study soon after their 16th birthday. All 44 participants had data at 12 months follow-up, with 24 left at 24 months, 14 at 36 months and 4 at 48 months. In view of this, outcome reporting was restricted to change from baseline to 12, 24 and 36 months.